Skip to content
AwardedRomaniaGoodsRON 358,003

Reactivi de laboraor si reactivi chimici -4 loturi, necesare pentru efectuarea activitatilor de cercetare in cadrul poiectului de cercetare PNRR 760067/23.05.2023, CF 81/15.11.2022, "Decoding the immuno-inflammatory axis in rare non-medullary thyroid cancer as an innovative approach for novel combinatory therapeutic approaches".

Published
Published 5 November 2025
Deadline
Closed 8 December 2025

Overview

Lotul 1: Kituri extractie si amplificare Lotul 2: Reactivi evaluare profil transcriptomic spatial Lotul 3: Reactivi chimici Lotul 4: Reactivi de laborator pentru PCR

Key details

Country
Romania
Status
Awarded
Category
Goods
Estimated value
RON 358,003
Procedure
Open
Published
5 November 2025
Deadline
Closed
Classification (CPV)
Chemical reagentsLaboratory reagents

Award outcome

Awarded value
RON 349,514
Award date
12 March 2026
Contract period
— → 11 May 2026
Winners
  • ANTISEL RO
  • Elta 90 Medical Research SRL
  • Omnivet Impex S.R.L.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    16 March 2026

  2. Contract Notice

    5 November 2025

Contracting authority

  • Universitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca

    Procuring entity

    Cluj-Napoca, Romania

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Reactivi de laboraor si reactivi chimici -4 loturi, necesare pentru efectuarea activitatilor de cercetare in cadrul poiectului de cercetare PNRR 760067/23.05.2023, CF 81/15.11.2022, "Decoding the immuno-inflammatory axis in rare non-medullary thyroid cancer as an innovative approach for novel combinatory therapeutic approaches". — won by ANTISEL RO +2 — Skim